Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency gives first opinion for a vaccine for use outside the EU 22 Junij 2012Press releaseCorporateMedicines European Medicines Agency recommends first medical treatment for patients with short bowel syndrome 22 Junij 2012Press releaseHumanMedicines European Medicines Agency recommends restricting use of tolperisone medicines 22 Junij 2012Press releaseCorporateMedicines European Medicines Agency advises doctors treating patients with nosocomial pneumonia with Doribax 22 Junij 2012Press releaseHumanMedicines European Medicines Agency recommends restricting use of trimetazidine-containing medicines 22 Junij 2012Press releaseCorporateMedicines European Medicines Agency acts on deficiencies in Roche medicines-safety reporting 21 Junij 2012Press releaseCorporateMedicines Celgene Europe Limited withdraws its application for an extension of the indication for Revlimid (lenalidomide) 21 Junij 2012Press releaseCorporate European Medicines Agency reminds marketing-authorisation holders about requirement for paediatric annual reports 21 Junij 2012NewsHumanMedicinesPaediatrics Concept paper on fees for new pharmacovigilance activities released for public consultation 20 Junij 2012NewsCorporate Committee for Orphan Medicinal Products (COMP) June 2012 highlights 18 Junij 2012NewsHumanRare diseases 1 … 250 251 252 253 254 Page 254 of 384 255 256 257 258 … 384
European Medicines Agency gives first opinion for a vaccine for use outside the EU 22 Junij 2012Press releaseCorporateMedicines
European Medicines Agency recommends first medical treatment for patients with short bowel syndrome 22 Junij 2012Press releaseHumanMedicines
European Medicines Agency recommends restricting use of tolperisone medicines 22 Junij 2012Press releaseCorporateMedicines
European Medicines Agency advises doctors treating patients with nosocomial pneumonia with Doribax 22 Junij 2012Press releaseHumanMedicines
European Medicines Agency recommends restricting use of trimetazidine-containing medicines 22 Junij 2012Press releaseCorporateMedicines
European Medicines Agency acts on deficiencies in Roche medicines-safety reporting 21 Junij 2012Press releaseCorporateMedicines
Celgene Europe Limited withdraws its application for an extension of the indication for Revlimid (lenalidomide) 21 Junij 2012Press releaseCorporate
European Medicines Agency reminds marketing-authorisation holders about requirement for paediatric annual reports 21 Junij 2012NewsHumanMedicinesPaediatrics
Concept paper on fees for new pharmacovigilance activities released for public consultation 20 Junij 2012NewsCorporate
Committee for Orphan Medicinal Products (COMP) June 2012 highlights 18 Junij 2012NewsHumanRare diseases